Literature DB >> 27144627

Bowel Disorders.

Fermín Mearin1, Brian E Lacy2, Lin Chang3, William D Chey4, Anthony J Lembo5, Magnus Simren6, Robin Spiller7.   

Abstract

Functional bowel disorders are highly prevalent disorders found worldwide. These disorders have the potential to affect all members of society, regardless of age, gender, race, creed, color or socioeconomic status. Improving our understanding of functional bowel disorders (FBD) is critical as they impose a negative economic impact to the global health care system in addition to reducing quality of life. Research in the basic and clinical sciences during the past decade has produced new information on the epidemiology, etiology, pathophysiology, diagnosis and treatment of FBDs. These important findings created a need to revise the Rome III criteria for FBDs, last published in 2006. This manuscript classifies the FBDs into five distinct categories: irritable bowel syndrome (IBS); functional constipation (FC); functional diarrhea (FDr); functional abdominal bloating/distention (FAB/D); and unspecified FBD (U-FBD). Also included in this article is a new sixth category, opioid induced constipation (OIC) which is distinct from the functional bowel disorders (FBDs). Each disorder will first be defined, followed by sections on epidemiology, rationale for changes from prior criteria, clinical evaluation, physiologic features, psychosocial features and treatment. It is the hope of this committee that this new information will assist both clinicians and researchers in the decade to come.
Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  abdominal pain; bloating; constipation; diarrhea; distension; functional bowel disorders; irritable bowel syndrome

Year:  2016        PMID: 27144627     DOI: 10.1053/j.gastro.2016.02.031

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  321 in total

Review 1.  New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond.

Authors:  Emanuele Sinagra; Gaetano Cristian Morreale; Ghazaleh Mohammadian; Giorgio Fusco; Valentina Guarnotta; Giovanni Tomasello; Francesco Cappello; Francesca Rossi; Georgios Amvrosiadis; Dario Raimondo
Journal:  World J Gastroenterol       Date:  2017-09-28       Impact factor: 5.742

2.  Bloating in Irritable Bowel Syndrome Is Associated with Symptoms Severity, Psychological Factors, and Comorbidities.

Authors:  Keren Hod; Yehuda Ringel; Miranda A L van Tilburg; Tamar Ringel-Kulka
Journal:  Dig Dis Sci       Date:  2018-12-18       Impact factor: 3.199

3.  Adherent-Invasive E. coli enhances colonic hypersensitivity and P2X receptors expression during post-infectious period.

Authors:  Amandine Lashermes; Ludivine Boudieu; Julie Barbier; Benoit Sion; Agathe Gelot; Nicolas Barnich; Denis Ardid; Frédéric Antonio Carvalho
Journal:  Gut Microbes       Date:  2017-10-04

Review 4.  Pathophysiology, Evaluation, and Management of Chronic Watery Diarrhea.

Authors:  Michael Camilleri; Joseph H Sellin; Kim E Barrett
Journal:  Gastroenterology       Date:  2016-10-20       Impact factor: 22.682

Review 5.  Will MRI of gastrointestinal function parallel the clinical success of cine cardiac MRI?

Authors:  Caroline Hoad; Christopher Clarke; Luca Marciani; Martin John Graves; Maura Corsetti
Journal:  Br J Radiol       Date:  2018-10-24       Impact factor: 3.039

6.  5-oxoETE triggers nociception in constipation-predominant irritable bowel syndrome through MAS-related G protein-coupled receptor D.

Authors:  Tereza Bautzova; James R F Hockley; Teresa Perez-Berezo; Julien Pujo; Michael M Tranter; Cleo Desormeaux; Maria Raffaella Barbaro; Lilian Basso; Pauline Le Faouder; Corinne Rolland; Pascale Malapert; Aziz Moqrich; Helene Eutamene; Alexandre Denadai-Souza; Nathalie Vergnolle; Ewan St John Smith; David I Hughes; Giovanni Barbara; Gilles Dietrich; David C Bulmer; Nicolas Cenac
Journal:  Sci Signal       Date:  2018-12-18       Impact factor: 8.192

Review 7.  Integrative Medicine for Gastrointestinal Disease.

Authors:  Michelle L Dossett; Ezra M Cohen; Jonah Cohen
Journal:  Prim Care       Date:  2017-06       Impact factor: 2.907

8.  Inhibition of Cav 3.2 calcium channels: A new target for colonic hypersensitivity associated with low-grade inflammation.

Authors:  Elodie Picard; Frederic Antonio Carvalho; Francina Agosti; Emmanuel Bourinet; Denis Ardid; Alain Eschalier; Laurence Daulhac; Christophe Mallet
Journal:  Br J Pharmacol       Date:  2019-03-11       Impact factor: 8.739

9.  Bioelectrical impedance vector analysis in patients with irritable bowel syndrome on a low FODMAP diet: a pilot study.

Authors:  M Bellini; D Gambaccini; L Bazzichi; G Bassotti; M G Mumolo; B Fani; F Costa; A Ricchiuti; N De Bortoli; M Mosca; S Marchi; A Rossi
Journal:  Tech Coloproctol       Date:  2017-05-31       Impact factor: 3.781

Review 10.  An interprofessional approach to managing children with treatment-resistant enuresis: an educational review.

Authors:  Patrina H Y Caldwell; Melissa Lim; Gail Nankivell
Journal:  Pediatr Nephrol       Date:  2017-11-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.